Consulting Services
For Investors
- Lucid Diligence Briefs
- Venture Capital
Case Studies
Insights
- Conference Previews
- Conference Social Media Reports
LucidWargames
QuickAnswers
LucidSearch
BioPharma and Tech News

Contact Us

Search

Cagrilintide

Obesity Weekly News

Obesity Video Recap—January 5, 2026

This Obesity video recap highlights major Phase 3 readouts, new regulatory…

Obesity Weekly News

Obesity Today—January 5, 2026

This Obesity roundup highlights major clinical milestones, regulatory filings,…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Rare Disease News
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Women’s Health Video Recap—January 7, 2026
Neuroscience Video Recap—January 7, 2026
Neuroscience Today — January 7, 2026
Lucid Diligence Brief: Amgen acquires Dark Blue Therapeutics
Lucid Diligence Brief: Halozyme × Skye Bioscience evaluating ENHANZE + nimacimab in obesity

Tags

510(k) Acute lymphoblastic leukemia AHA Go Red AI in neurology ANAVEX 3-71 Arialys B7-H3 biomarin pharmaceutical CNSide CSF assay Corcept data linkage DELIVER Efsubaglutide Alfa Elixir Medical ENDO 2025 endoluminal robotics Etana Evaxion FKRP FSHD Hippo pathway IL-6 lentiviral gene therapy lunit MannKind MD Codes mesothelin multispecific antibodies ovarian cancer research PureTech Health Quotient Therapeutics Qure.ai RNA-based gene therapy Rocket Pharmaceuticals Saudi Arabia Soligenix Systemic lupus erythematosus Takeda Pharmaceuticals TCR therapy TnpB transcatheter implant TSHA-102 ublituximab-xiiy VitriVax WINREVAIR

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Women’s Health Video Recap—January 7, 2026
Neuroscience Video Recap—January 7, 2026
Neuroscience Today — January 7, 2026
Lucid Diligence Brief: Amgen acquires Dark Blue Therapeutics
Lucid Diligence Brief: Halozyme × Skye Bioscience evaluating ENHANZE + nimacimab in obesity

TAGS

510(k) Acute lymphoblastic leukemia AHA Go Red AI in neurology ANAVEX 3-71 Arialys B7-H3 biomarin pharmaceutical CNSide CSF assay Corcept data linkage DELIVER Efsubaglutide Alfa Elixir Medical ENDO 2025 endoluminal robotics Etana Evaxion FKRP FSHD Hippo pathway IL-6 lentiviral gene therapy lunit MannKind MD Codes mesothelin multispecific antibodies ovarian cancer research PureTech Health Quotient Therapeutics Qure.ai RNA-based gene therapy Rocket Pharmaceuticals Saudi Arabia Soligenix Systemic lupus erythematosus Takeda Pharmaceuticals TCR therapy TnpB transcatheter implant TSHA-102 ublituximab-xiiy VitriVax WINREVAIR

Consulting Services
For Investors
- Lucid Diligence Briefs
- Venture Capital
Case Studies
Insights
- Conference Previews
- Conference Social Media Reports
LucidWargames
QuickAnswers
LucidSearch
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy